Asset Allocation & Management Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,253
Closed -$472K 99
2025
Q1
$472K Hold
5,253
0.24% 48
2024
Q4
$523K Buy
+5,253
New +$542K 0.29% 41
2023
Q1
Sell
-5,253
Closed -$583K 112
2022
Q4
$583K Sell
5,253
-6
-0.1% -$613 0.23% 65
2022
Q3
$453K Buy
5,259
+6
+0.1% +$536 0.19% 72
2022
Q2
$479K Hold
5,253
0.2% 71
2022
Q1
$431K Hold
5,253
0.15% 92
2021
Q4
$403K Buy
+5,253
New +$418K 0.14% 88
2020
Q1
Sell
-2,541
Closed -$221K 62
2019
Q4
$221K Buy
+2,541
New +$209K 0.08% 57

Other funds holding MRK

Asset Allocation & Management Company's MRK Position: Q2 2025 in Review

Asset Allocation & Management Company sold out of Merck (MRK) in Q2 2025, closing a stake of 5,253 shares — an estimated $472K sold.

Asset Allocation & Management Company first reported a position in MRK in Q4 2019 and held it in 8 quarters. The position peaked at $583K in Q4 2022. 3,328 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Asset Allocation & Management Company reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Asset Allocation & Management Company sold 5,253 Merck shares in Q2 2025, an estimated $472K.
  • Asset Allocation & Management Company first reported a position in Merck in Q4 2019 and held it in 8 quarters.
  • Asset Allocation & Management Company's Merck position peaked at $583K in Q4 2022.
  • 3,328 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Asset Allocation & Management Company's 13F filing for Q2 2025, filed 16 Jul 2025.